{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:14:24Z","timestamp":1790712864672,"version":"4.1.0"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007301","name":"Kunming University of Science and Technology","doi-asserted-by":"publisher","award":["KKZ3202560054"],"award-info":[{"award-number":["KKZ3202560054"]}],"id":[{"id":"10.13039\/501100007301","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart & Vasculature"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ijcha.2026.102010","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T10:17:43Z","timestamp":1790331463000},"page":"102010","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Altered Acylcarnitine Metabolism in cardiac diseases: From molecular mechanisms to translational potential"],"prefix":"10.1016","volume":"67","author":[{"given":"Jiazhen","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhua","family":"Dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcha.2026.102010_bb0005","series-title":"Statpearls","article-title":"Cardiovascular Disease","author":"Olvera Lopez","year":"2025"},{"key":"10.1016\/j.ijcha.2026.102010_bb0010","first-page":"893","article-title":"Interpretation of annual report on cardiovascular health and diseases in China 2024","volume":"38","author":"Liu","year":"2025","journal-title":"Biomed. Environ. Sci. BES"},{"key":"10.1016\/j.ijcha.2026.102010_bb0015","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","article-title":"Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of disease study 2021","volume":"403","year":"2024","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.ijcha.2026.102010_bb0020","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.4244\/EIJ-D-21-00192","article-title":"Temporal trends in clinical outcomes after percutaneous coronary intervention: a systematic review of 66,327 patients from 25 all-comers trials","volume":"17","author":"Asano","year":"2022","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ijcha.2026.102010_bb0025","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","article-title":"Cardiac energy metabolism in heart failure","volume":"128","author":"Lopaschuk","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcha.2026.102010_bb0030","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1093\/cvr\/cvae231","article-title":"Advances in myocardial energy metabolism: metabolic remodelling in heart failure and beyond","volume":"120","author":"Sun","year":"2024","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcha.2026.102010_bb0035","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41569-022-00760-3","article-title":"Branched-chain amino acids in cardiovascular disease","volume":"20","author":"McGarrah","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ijcha.2026.102010_bb0040","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cmet.2007.10.013","article-title":"Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance","volume":"7","author":"Koves","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.ijcha.2026.102010_bb0045","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.cmet.2023.03.016","article-title":"Pyruvate-supported flux through medium-chain ketothiolase promotes mitochondrial lipid tolerance in cardiac and skeletal muscles","volume":"35","author":"Koves","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.ijcha.2026.102010_bb0050","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nrendo.2015.129","article-title":"Acylcarnitines--old actors auditioning for new roles in metabolic physiology","volume":"11","author":"McCoin","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ijcha.2026.102010_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.advnut.2024.100336","article-title":"Carnitine","volume":"15","author":"Lin","year":"2024","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.ijcha.2026.102010_bb0060","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.bbamcr.2016.01.023","article-title":"Carnitine transport and fatty acid oxidation","volume":"1863","author":"Longo","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijcha.2026.102010_bb0065","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/metabo11010051","article-title":"L-carnitine and acylcarnitines: mitochondrial biomarkers for precision medicine","volume":"11","author":"McCann","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.ijcha.2026.102010_bb0070","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41580-022-00572-w","article-title":"Metabolites as signalling molecules","volume":"24","author":"Baker","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ijcha.2026.102010_bb0075","doi-asserted-by":"crossref","first-page":"8468","DOI":"10.3390\/ijms22168468","article-title":"Long-chain acyl-carnitines interfere with mitochondrial ATP production leading to cardiac dysfunction in zebrafish","volume":"22","author":"Park","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijcha.2026.102010_bb0080","doi-asserted-by":"crossref","first-page":"7461","DOI":"10.3390\/ijms21207461","article-title":"Dissecting cellular mechanisms of long-chain acylcarnitines-driven cardiotoxicity: disturbance of calcium homeostasis, activation of Ca2+\u2212dependent phospholipases, and mitochondrial energetics collapse","volume":"21","author":"Berezhnov","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijcha.2026.102010_bb0085","doi-asserted-by":"crossref","first-page":"E1378","DOI":"10.1152\/ajpendo.00656.2013","article-title":"Acylcarnitines activate proinflammatory signaling pathways","volume":"306","author":"Rutkowsky","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ijcha.2026.102010_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.577856","article-title":"Long-chain acylcarnitines and cardiac excitation-contraction coupling: links to arrhythmias","volume":"11","author":"Aitken-Buck","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ijcha.2026.102010_bb0095","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1186\/s12967-023-04420-z","article-title":"An arrhythmogenic metabolite in atrial fibrillation","volume":"21","author":"Krause","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ijcha.2026.102010_bb0100","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1111\/jcmm.17949","article-title":"Study of amphipathic metabolites in cardiac pathophysiology: insights gained from long-chain acylcarnitines and calcium handling","volume":"27","author":"Aitken-Buck","year":"2023","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.ijcha.2026.102010_bb0105","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.33549\/physiolres.935261","article-title":"Metabolic pathways of acylcarnitine synthesis","volume":"73","author":"Brejchova","year":"2024","journal-title":"Physiol. Res."},{"key":"10.1016\/j.ijcha.2026.102010_bb0110","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41420-025-02554-1","article-title":"The role and mechanism of fatty acid oxidation in cancer drug resistance","volume":"11","author":"Lei","year":"2025","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.ijcha.2026.102010_bb0115","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/s12967-025-06341-5","article-title":"Comprehensive review of the expanding roles of the carnitine pool in metabolic physiology: beyond fatty acid oxidation","volume":"23","author":"Xiang","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ijcha.2026.102010_bb0120","first-page":"1","article-title":"Often forgotten but essential: long-chain acyl-CoAs in metabolic control","author":"F\u00e6rgeman","year":"2026","journal-title":"Nat. Metab."},{"key":"10.1016\/j.ijcha.2026.102010_bb0125","article-title":"Pathophysiological roles of the serum acylcarnitine level and acylcarnitine\/free carnitine ratio in patients with cardiovascular diseases","volume":"51","year":"2024","journal-title":"Int. J. Cardiol. Heart. Vasc."},{"key":"10.1016\/j.ijcha.2026.102010_bb0130","doi-asserted-by":"crossref","first-page":"eadf0115","DOI":"10.1126\/sciadv.adf0115","article-title":"Acetylcarnitine shuttling links mitochondrial metabolism to histone acetylation and lipogenesis","volume":"9","author":"Izzo","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ijcha.2026.102010_bb0135","doi-asserted-by":"crossref","first-page":"13717","DOI":"10.1038\/s41598-022-18266-w","article-title":"Pentadecanoylcarnitine is a newly discovered endocannabinoid with pleiotropic activities relevant to supporting physical and mental health","volume":"12","author":"Venn-Watson","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijcha.2026.102010_bb0140","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.bpj.2020.01.013","article-title":"Acylcarnitines at the membrane surface: insertion parameters for a mitochondrial leaflet model","volume":"118","author":"Anwer","year":"2020","journal-title":"Biophys. J."},{"key":"10.1016\/j.ijcha.2026.102010_bb0145","doi-asserted-by":"crossref","DOI":"10.1002\/biof.70014","article-title":"EPA and DHA acylcarnitines are less cardiotoxic than are saturated and monounsaturated long-chain acylcarnitines","volume":"51","author":"Liepinsh","year":"2025","journal-title":"BioFactors"},{"key":"10.1016\/j.ijcha.2026.102010_bb0150","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1016\/j.ijcard.2012.04.150","article-title":"Disturbed carnitine regulation in chronic heart failure \u2014 increased plasma levels of palmitoyl-carnitine are associated with poor prognosis","volume":"167","author":"Ueland","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcha.2026.102010_bb0155","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jacc.2015.10.079","article-title":"Long-chain acylcarnitine metabolites are associated with adverse outcomes and reversible with mechanical circulatory support in systolic heart failure","volume":"67","author":"Ahmad","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcha.2026.102010_bb0160","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3390\/jcdd10100438","article-title":"Relationship of acylcarnitines to myocardial ischemic remodeling and clinical manifestations in chronic heart failure","volume":"10","author":"Belenkov","year":"2023","journal-title":"J. Cardiovasc. Dev. Dis."},{"key":"10.1016\/j.ijcha.2026.102010_bb0165","article-title":"Targeting long-chain acylcarnitine accumulation to protect cardiac mitochondrial homeostasis after complete revascularization","volume":"6","author":"Lin","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.ijcha.2026.102010_bb0170","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/s00018-002-8445-3","article-title":"Thyroid hormone controls carnitine status through modifications of gamma-butyrobetaine hydroxylase activity and gene expression","volume":"59","author":"Galland","year":"2002","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"10.1016\/j.ijcha.2026.102010_bb0175","article-title":"Important hormones regulating lipid metabolism","volume":"27","author":"Zhang","year":"2022","journal-title":"Molecules (Basel, Switzerland)"},{"key":"10.1016\/j.ijcha.2026.102010_bb0180","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41467-025-66867-6","article-title":"Structural basis of sodium ion-dependent carnitine transport by OCTN2","volume":"17","author":"Davies","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijcha.2026.102010_bb0185","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1096\/fj.12-216689","article-title":"Carnitine palmitoyltransferase 2 and carnitine\/acylcarnitine translocase are involved in the mitochondrial synthesis and export of acylcarnitines","volume":"27","author":"Violante","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.ijcha.2026.102010_bb0190","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1194\/jlr.M200137-JLR200","article-title":"Interactions of acyl carnitines with model membranes","volume":"43","author":"Ho","year":"2002","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ijcha.2026.102010_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002478","article-title":"Insulin signaling regulates fatty acid catabolism at the level of CoA activation","volume":"8","author":"Xu","year":"2012","journal-title":"PLoS Genet."},{"key":"10.1016\/j.ijcha.2026.102010_bb0200","first-page":"511","article-title":"Lean heart: role of leptin in cardiac hypertrophy and metabolism, world","volume":"7","author":"Hall","year":"2015","journal-title":"J. Cardiol."},{"key":"10.1016\/j.ijcha.2026.102010_bb0205","article-title":"Acetyl-CoA carboxylases and diseases","volume":"12","author":"Wang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ijcha.2026.102010_bb0210","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.freeradbiomed.2021.01.036","article-title":"Energy substrate metabolism and mitochondrial oxidative stress in cardiac ischemia\/reperfusion injury","volume":"165","author":"Dambrova","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ijcha.2026.102010_bb0215","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1111\/bph.16363","article-title":"Hydroxymethylglutaryl-CoA reductase activity is essential for mitochondrial \u03b2-oxidation of fatty acids to prevent lethal accumulation of long-chain acylcarnitines in the mouse liver","volume":"181","author":"Liepinsh","year":"2024","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ijcha.2026.102010_bb0220","unstructured":"J.A. Morales Corado, C.U. Lee, G.M. Enns, Carnitine-acylcarnitine translocase deficiency, in: M.P. Adam, S. Bick, G.M. Mirzaa, R.A. Pagon, S.E. Wallace, A. Amemiya (Eds.), GeneReviews\u00ae, University of Washington, Seattle, Seattle (WA), 1993. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK582032\/ (accessed January 29, 2026)."},{"key":"10.1016\/j.ijcha.2026.102010_bb0225","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11154-018-9448-1","article-title":"Disorders of mitochondrial long-chain fatty acid oxidation and the carnitine shuttle","volume":"19","author":"Knottnerus","year":"2018","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.ijcha.2026.102010_bb0230","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s13730-023-00804-8","article-title":"Adult-onset carnitine palmitoyl transferase II (CPT II) deficiency presenting with rhabdomyolysis and acute kidney injury","volume":"13","author":"Akar","year":"2023","journal-title":"CEN Case Rep."},{"key":"10.1016\/j.ijcha.2026.102010_bb0235","first-page":"4204","article-title":"Associations of plasma acylcarnitine and bile acid levels with incidence of coronary heart disease in Chinese adults","volume":"104","author":"Wu","year":"2024","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.ijcha.2026.102010_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.792350","article-title":"Metabolic impairment in coronary artery disease: elevated serum acylcarnitines under the spotlights","volume":"8","author":"Gander","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.ijcha.2026.102010_bb0245","doi-asserted-by":"crossref","first-page":"H162","DOI":"10.1152\/ajpheart.00184.2021","article-title":"Long-chain acylcarnitine 18:1 acutely increases human atrial myocardial contractility and arrhythmia susceptibility","volume":"321","author":"Aitken-Buck","year":"2021","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ijcha.2026.102010_bb0250","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41586-026-10584-7","article-title":"\u03b1KG-mediated carnitine synthesis drives DNA repair via histone acetylation","volume":"655","author":"Uboveja","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.ijcha.2026.102010_bb0255","article-title":"Palmitoylcarnitine impairs immunity in decompensated cirrhosis","volume":"6","author":"Zhang","year":"2024","journal-title":"JHEP Rep."},{"key":"10.1016\/j.ijcha.2026.102010_bb0260","doi-asserted-by":"crossref","unstructured":"M. Schooneman, G. Have, N. van Vlies, S. Houten, N. Deutz, M. Soeters, Transorgan fluxes in a porcine model reveal a central role for liver in acylcarnitine metabolism, Am. J. Physiol. Endocrinol. Metab. 309 (2015) ajpendo.503.2014. Doi: https:\/\/doi.org\/10.1152\/ajpendo.00503.2014.","DOI":"10.1152\/ajpendo.00503.2014"},{"key":"10.1016\/j.ijcha.2026.102010_bb0265","doi-asserted-by":"crossref","first-page":"5044","DOI":"10.1210\/jc.2016-1859","article-title":"Liver and muscle contribute differently to the plasma acylcarnitine pool during fasting and exercise in humans","volume":"101","author":"Xu","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ijcha.2026.102010_bb0270","doi-asserted-by":"crossref","first-page":"17528","DOI":"10.1038\/s41598-017-17797-x","article-title":"Plasma acylcarnitine concentrations reflect the acylcarnitine profile in cardiac tissues","volume":"7","author":"Makrecka-Kuka","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijcha.2026.102010_bb0275","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1161\/CIRCULATIONAHA.122.061846","article-title":"Myocardial metabolomics of human heart failure with preserved ejection fraction","volume":"147","author":"Hahn","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.ijcha.2026.102010_bb0280","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1053\/j.jrn.2006.01.004","article-title":"Relationship between serum carnitine, acylcarnitines, and renal function in patients with chronic renal disease","volume":"16","author":"Fouque","year":"2006","journal-title":"J. Ren. Nutr."},{"key":"10.1016\/j.ijcha.2026.102010_bb0285","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000542","article-title":"A plasma long-chain acylcarnitine predicts cardiovascular mortality in incident dialysis patients","volume":"2","author":"Kalim","year":"2013","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijcha.2026.102010_bb0290","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1038\/oby.2009.510","article-title":"Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity","volume":"18","author":"Mihalik","year":"2010","journal-title":"Obesity"},{"key":"10.1016\/j.ijcha.2026.102010_bb0295","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1017\/S0007114524001934","article-title":"Serum concentrations of lipids, ketones and acylcarnitines during the postprandial and fasting state: the postprandial metabolism (PoMet) study in healthy young adults","volume":"132","author":"Anfinsen","year":"2024","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.ijcha.2026.102010_bb0300","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.3390\/biomedicines10081938","article-title":"Pathophysiology of cardiovascular diseases: new insights into molecular mechanisms of atherosclerosis, arterial hypertension, and coronary artery disease","volume":"10","author":"Fr\u0105k","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.ijcha.2026.102010_bb0305","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70418","article-title":"Acute myocardial infarction: molecular pathogenesis, diagnosis, and clinical management","volume":"6","author":"Zhu","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.ijcha.2026.102010_bb0310","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41569-020-0403-y","article-title":"Myocardial ischaemia\u2013reperfusion injury and cardioprotection in perspective","volume":"17","author":"Heusch","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ijcha.2026.102010_bb0315","article-title":"Mitochondrial oxidative stress, calcium and dynamics in cardiac ischaemia-reperfusion injury","author":"Rozich","year":"2025","journal-title":"J. Physiol."},{"key":"10.1016\/j.ijcha.2026.102010_bb0320","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.apsb.2020.03.004","article-title":"Mitochondrial quality control mechanisms as molecular targets in cardiac ischemia\u2013reperfusion injury","volume":"10","author":"Wang","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ijcha.2026.102010_bb0325","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/s41569-025-01142-1","article-title":"Mitochondrial quality control in cardiomyocytes: safeguarding the heart against disease and ageing","volume":"22","author":"Ravindran","year":"2025","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ijcha.2026.102010_bb0330","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.yjmcc.2025.06.013","article-title":"Diabetic cardiomyopathy: insights into pathophysiology, diagnosis and clinical management","volume":"206","author":"Chen","year":"2025","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ijcha.2026.102010_bb0335","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2020.01.018","article-title":"Lipid accumulation in hearts transplanted from nondiabetic donors to diabetic recipients","volume":"75","author":"Marfella","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcha.2026.102010_bb0340","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.amjmed.2024.10.026","article-title":"Diabetic cardiomyopathy: what clinicians should know","volume":"138","author":"Smati","year":"2025","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ijcha.2026.102010_bb0345","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.00212","article-title":"The association between acylcarnitine metabolites and cardiovascular disease in Chinese patients with type 2 diabetes mellitus","volume":"11","author":"Zhao","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ijcha.2026.102010_bb0350","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12944-021-01576-9","article-title":"Medium & long-chain acylcarnitine\u2019s relation to lipid metabolism as potential predictors for diabetic cardiomyopathy: a metabolomic study","volume":"20","author":"Zheng","year":"2021","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.ijcha.2026.102010_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103184","article-title":"Sirt5 improves cardiomyocytes fatty acid metabolism and ameliorates cardiac lipotoxicity in diabetic cardiomyopathy via CPT2 de-succinylation","volume":"73","author":"Wu","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.ijcha.2026.102010_bb0360","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.cmet.2013.11.013","article-title":"SIRT5 regulates the mitochondrial lysine succinylome and metabolic networks","volume":"18","author":"Rardin","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.ijcha.2026.102010_bb0365","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1093\/cvr\/cvy060.302","article-title":"433Metabolomics in translational medicine - a link between acylcarnitines and atrial fibrillation","volume":"114","author":"Krause","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcha.2026.102010_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2025.101322","article-title":"Global, regional, and national burden of atrial fibrillation and atrial flutter in the working-age population from 1990 to 2021: a systematic analysis based on 2021 global burden of disease data","volume":"24","author":"Yang","year":"2025","journal-title":"Am. J. Prev. Cardiol."},{"key":"10.1016\/j.ijcha.2026.102010_bb0375","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0140-6736(25)02166-X","article-title":"Atrial fibrillation","volume":"407","author":"Lane","year":"2026","journal-title":"Lancet"},{"key":"10.1016\/j.ijcha.2026.102010_bb0380","first-page":"933","article-title":"Cardiogeriatrics: the current state of the art","volume":"110","author":"Gaur","year":"2024","journal-title":"Heart Br. Card. Soc."},{"key":"10.1016\/j.ijcha.2026.102010_bb0385","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.003190","article-title":"Metabolomic profiling identifies novel circulating biomarkers of mitochondrial dysfunction differentially elevated in heart failure with preserved versus reduced ejection fraction: evidence for shared metabolic impairments in clinical heart failure","volume":"5","author":"Hunter","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijcha.2026.102010_bb0390","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124844","article-title":"Metabolomic fingerprint of heart failure with preserved ejection fraction","volume":"10","author":"Zordoky","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcha.2026.102010_bb0395","article-title":"Circulating acylcarnitine profile in human heart failure: a surrogate of fatty acid metabolic dysregulation in mitochondria and beyond","volume":"313","author":"M","year":"2017","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ijcha.2026.102010_bb0400","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038812","article-title":"Metabolomic profiling reveals mitochondrial-derived lipid biomarkers that drive obesity-associated inflammation","volume":"7","author":"Sampey","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcha.2026.102010_bb0405","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s44161-024-00585-y","article-title":"Mechanical regulation of macrophage metabolism by allograft inflammatory factor 1 leads to adverse remodeling after cardiac injury","volume":"4","author":"DeBerge","year":"2025","journal-title":"Nat. Cardiovasc. Res."},{"key":"10.1016\/j.ijcha.2026.102010_bb0410","article-title":"Myocardial injury: where inflammation and autophagy meet, burns","volume":"11","author":"Liu","year":"2023","journal-title":"Trauma"},{"key":"10.1016\/j.ijcha.2026.102010_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.arres.2025.100149","article-title":"Role of L-carnitine in exercise training: anti-inflammatory, antioxidant, and metabolic interactions","volume":"18","author":"Aminizadeh","year":"2026","journal-title":"Adv. Redox Res."},{"key":"10.1016\/j.ijcha.2026.102010_bb0420","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ahj.2012.02.005","article-title":"Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease","volume":"163","author":"Shah","year":"2012","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcha.2026.102010_bb0425","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.109.852814","article-title":"Association of a peripheral blood metabolic profile with coronary artery disease and risk of subsequent cardiovascular events","author":"Shah","year":"2010","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.ijcha.2026.102010_bb0430","doi-asserted-by":"crossref","first-page":"13159","DOI":"10.1074\/jbc.M212356200","article-title":"Structure of human carnitine acetyltransferase. Molecular basis for fatty acyl transfer","volume":"278","author":"Wu","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijcha.2026.102010_bb0435","doi-asserted-by":"crossref","first-page":"31584","DOI":"10.1074\/jbc.M403484200","article-title":"Structural and biochemical studies of the substrate selectivity of carnitine acetyltransferase*","volume":"279","author":"Hsiao","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijcha.2026.102010_bb0440","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.744023","article-title":"Mitochondrial contributions in the genesis of delayed afterdepolarizations in ventricular myocytes","volume":"12","author":"Pandey","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ijcha.2026.102010_bb0445","article-title":"Mitochondrial-mediated oxidative Ca2+\/calmodulin-dependent kinase II activation induces early afterdepolarizations in guinea pig cardiomyocytes: An in silico study","volume":"7","author":"Yang","year":"2018","journal-title":"J. Am. Heart Assoc. Cardiovasc. Cerebrovasc. Dis."},{"key":"10.1016\/j.ijcha.2026.102010_bb0450","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00395-021-00900-9","article-title":"Cardiomyocyte na+ and Ca2+ mishandling drives vicious cycle involving CaMKII, ROS, and ryanodine receptors","volume":"116","author":"Hegyi","year":"2021","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.ijcha.2026.102010_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2025.343856","article-title":"Isomer-resolved characterization of acylcarnitines reveals alterations in type 2 diabetes","volume":"1351","author":"Gao","year":"2025","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.ijcha.2026.102010_bb0460","article-title":"Pathophysiological roles of the serum acylcarnitine level and acylcarnitine\/free carnitine ratio in patients with cardiovascular diseases","volume":"51","author":"Nakajima","year":"2024","journal-title":"Int. J. Cardiol. Heart. Vasc."},{"key":"10.1016\/j.ijcha.2026.102010_bb0465","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1373\/clinchem.2016.255174","article-title":"Growth differentiation factor 15 as a biomarker in cardiovascular disease","volume":"63","author":"Wollert","year":"2017","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ijcha.2026.102010_bb0470","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10741-022-10268-0","article-title":"Fibroblast growth factor 21 in heart failure","volume":"28","author":"Tucker","year":"2023","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.ijcha.2026.102010_bb0475","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s44161-023-00259-1","article-title":"Ketones and the cardiovascular system","volume":"2","author":"Lopaschuk","year":"2023","journal-title":"Nat. Cardiovasc. Res."},{"key":"10.1016\/j.ijcha.2026.102010_bb0480","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.jacc.2020.12.065","article-title":"Therapeutic potential of ketone bodies for patients with cardiovascular disease","volume":"77","author":"Yurista","year":"2021","journal-title":"Jacc"},{"key":"10.1016\/j.ijcha.2026.102010_bb0485","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.1038\/s41467-024-50125-2","article-title":"Plasma metabolomics reveals the shared and distinct metabolic disturbances associated with cardiovascular events in coronary artery disease","volume":"15","author":"Lv","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijcha.2026.102010_bb0490","article-title":"Comprehensive metabolomic profiling and incident cardiovascular disease: a systematic review","volume":"6","author":"Ruiz-Canela","year":"2017","journal-title":"J. Am. Heart Assoc. Cardiovasc. Cerebrovasc. Dis."},{"key":"10.1016\/j.ijcha.2026.102010_bb0495","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1161\/CIRCULATIONAHA.122.062166","article-title":"Retained metabolic flexibility of the failing human heart","volume":"148","author":"Watson","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.ijcha.2026.102010_bb0500","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1042\/CS20060307","article-title":"A double-blind randomized multicentre clinical trial to evaluate the efficacy and safety of two doses of etomoxir in comparison with placebo in patients with moderate congestive heart failure: the ERGO (etomoxir for the recovery of glucose oxidation) study","volume":"113","author":"Holubarsch","year":"2007","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ijcha.2026.102010_bb0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2024.100604","article-title":"Etomoxir: an old dog with new tricks","volume":"65","author":"McGuffee","year":"2024","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ijcha.2026.102010_bb0510","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1161\/CIRCULATIONAHA.105.551457","article-title":"Metabolic modulation with perhexiline in chronic heart failure","volume":"112","author":"Lee","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ijcha.2026.102010_bb0515","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s10557-016-6664-3","article-title":"Drugs that affect cardiac metabolism: focus on perhexiline","volume":"30","author":"Chong","year":"2016","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ijcha.2026.102010_bb0520","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1527-3466.2007.00006.x","article-title":"Perhexiline","volume":"25","author":"Ashrafian","year":"2007","journal-title":"Cardiovasc. Drug Rev."},{"key":"10.1016\/j.ijcha.2026.102010_bb0525","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.mayocp.2013.02.007","article-title":"L-carnitine in the secondary prevention of cardiovascular disease: systematic review and meta-analysis","volume":"88","author":"DiNicolantonio","year":"2013","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.ijcha.2026.102010_bb0530","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/6274854","article-title":"Efficacy and safety of L-carnitine treatment for chronic heart failure: a meta-analysis of randomized controlled trials","volume":"2017","author":"Song","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ijcha.2026.102010_bb0535","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12970-020-00377-2","article-title":"The bright and the dark sides of L-carnitine supplementation: a systematic review","volume":"17","author":"Sawicka","year":"2020","journal-title":"J. Int. Soc. Sports Nutr."},{"key":"10.1016\/j.ijcha.2026.102010_bb0540","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/dom.12248","article-title":"Inhibition of carnitine Palymitoyltransferase1b induces cardiac hypertrophy and mortality in mice, diabetes","volume":"16","author":"Haynie","year":"2014","journal-title":"Obes. Metab."},{"key":"10.1016\/j.ijcha.2026.102010_bb0545","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fcvm.2018.00068","article-title":"Loss of metabolic flexibility in the failing heart","volume":"5","author":"Karwi","year":"2018","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.ijcha.2026.102010_bb0550","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1161\/CIRCULATIONAHA.122.062166","article-title":"Retained metabolic flexibility of the failing human heart","volume":"148","author":"Watson","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.ijcha.2026.102010_bb0555","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11897-022-00554-1","article-title":"Targeting myocardial substrate metabolism in the failing heart: ready for prime time?","volume":"19","author":"Yurista","year":"2022","journal-title":"Curr. Heart Fail. Rep."},{"key":"10.1016\/j.ijcha.2026.102010_bb0560","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/ejhf.678","article-title":"Metabolic support for the heart: complementary therapy for heart failure?","volume":"18","author":"Heggermont","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcha.2026.102010_bb0565","doi-asserted-by":"crossref","DOI":"10.1002\/imo2.70096","article-title":"Progress of metabolomics-centric multi-omics research in medicine","volume":"3","author":"Wang","year":"2026","journal-title":"iMetaOmics"}],"container-title":["IJC Heart & Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906726001442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906726001442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:52:46Z","timestamp":1790711566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352906726001442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":113,"alternative-id":["S2352906726001442"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2026.102010","relation":{},"ISSN":["2352-9067"],"issn-type":[{"value":"2352-9067","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered Acylcarnitine Metabolism in cardiac diseases: From molecular mechanisms to translational potential","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2026.102010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102010"}}